Share warrant program 2018

Series 2018/2022 and Series 2018/2023

At an extraordinary general meeting on December 17, 2018, the shareholders decided to introduce an incentive program for all employees of the company and future key employees. The program was designed to stimulate the company’s staff and senior executives in the longer term and to promote investments in and ownership of the company’s shares. The program comprised a maximum of 1,461,698 warrants and the program was designed so that the warrants were transferred to market value according to a Black & Scholes calculation performed by Grant Thornton Sweden AB. At the end of each program, each warrant entitles the holder to subscribe for one new share in Isofol at a valid exercise price. The subscription price was set for series 18/22 at SEK 51.3 per share and for 18/23 at SEK 76.9 per share. 

For Series 18/22, the current exercise price amounts to SEK 28.3 per share (subscription period from May 15 to July 15, 2022) and for Series 18/23 the exercise price was SEK 42.5 per share (subscription period from May 15 to July 15, 2023) after recalculation in accordance with the program terms due to the company’s rights issues in June 2020 and June 2021.

All subscription periods have passed and no subscription options were exercised.

For more information we refer to:

Press release >>

Scroll to Top